APOA1 and coronary atherosclerosis: Intravenous infusions of complexes containing the apoA-I variant, apoA-IMilano and phospholipid (ETC-216) resulted in regression of coronary atherosclerosis measured byserial intravascular ultrasound in patients with a recent acute coronary syndrome(Nissenet al, 2003).